Who is speaking

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Cerlin Roberts at c.roberts@oxfordglobal.co.uk

2014 speakers include:

  • Steven Adams
    Executive Director, Portfolio & Business Operations Oncology Research Unit, Pfizer Worldwide Research & Development, USA
  • Jun Bao
    Senior Vice President, Shenogen Pharma Group, China
  • Nathan Chen
    Senior Director, Asia Clinical Development Head, Pfizer, China
  • Robert Chen
    Vice President, Global Strategy & Partnering, Genor BioPharma, China
  • Louis Chow
    Executive Director, Organisation for Oncology and Translational Research
  • Rebecca Dai
    Head GCP&SM, Global Clinical Development, Bayer Healthcare, China
  • Yuan-Hua Ding
    Senior Director, Head of External R&D Innovation – Asia/Pacific, Worldwide R&D, USA
  • Ulrich Dobrindt
    Professor, University of Münster
  • Carl Frith
    CEO, ASLAN Pharmaceutical, Singapore
  • Mark Goh
    Associate Professor, National University of Singapore, Director, The Logistics Institute – Asia Pacific, Singapore
  • Maggie Gu
    Director, Clinical Development, AstraZeneca, China
  • Ming Guo
    COO, Ascentage Pharma, China
  • Amy Jiang
    Head of Quality, Sanofi Pasteur, China
  • Pierre Letecheur
    Director, Servier Pharmaceutical Research & Development, China
  • Shell Li
    Head of Clinical Research, Executive Director, Boehringer Ingelheim, China
  • Jian Li
    Director, Partnering & External Innovation (Asia Pacific), Sanofi R&D, China
  • Jonathan Luke Heeney
    Professor of Comparative Pathology, Head, Lab of Viral Zoonotics, University of Cambridge
  • Hua Mu
    Executive Vice President & Chief Medical Officer, Hutchison Medi Pharma
  • Dan Paulson
    Global Clinical Leader, Cardiovascular Risk Management, Global Clinical Development, Bayer, China
  • Sylvie Sakata
    Senior Director, External Research Solutions West and Asia Region Lead, Pfizer, USA
  • Cezary Statuch
    Vice President, Head of China R&D, Bristol-Myers Squibb, China
  • Hiroshi Sugii
    Vice President, Novo Nordisk, Japan
  • Yongkui Sun
    VP, Greater China Lead, External Scientific Affairs, Worldwide Licensing and Acquisitions, MSD R&D, China
  • Dejun Tang
    Site Head, Biometrics & Statistical Sciences and Methodology. Novartis, China
  • Vincenzo Teneggi
    Senior Medical Director, D3, Agency for Science, Technology and Research (A*STAR), Singapore
  • Masakazu Toi
    Professor, Faculty of Medicine, Kyoto University, Japan
  • James Tsui
    Scientific Sourcing, Contracts & Outsourcing, Roche, China
  • Patrecia Valone
    Senior Director, Development Operations, Takeda Development Center Asia and Takeda Shanghai Development Center, Singapore
  • Brendan W. Wren
    Professor of Microbial Pathogenesis, London School of Hygiene & Tropical Medicine
  • Rebecca Wang
    Executive Medical Director, Bone Safety TA Head, Amgen, USA
  • Wei Wang
    Associate Director, Safety Surveillance and Risk Management, Pfizer, China
  • Zaiqi Wang
    Head of Clinical Research, Merck, China
  • Mingde Xia
    Senior Director, Johnson & Johnson, USA
  • Toshinori Yamamoto
    Vice President and Head of Preclinical Research, RaQualia Pharma Inc., Japan
  • Jin-San Yoo
    CEO and President of PharmAbcine, Inc. South Korea
  • Jimmy Z. Zhang
    Managing Director, MSD Early Investments, Merck & Co., Inc., China
  • Yumin Zhang
    Expert Scientific Advisor Medical Imaging, Abbvie, China
  • Kezhou Zhang
    Vice President, Novo Nordisk, China
  • Ming-Qiang Zhang
    Vice President & Head, Research and Development China, Amgen Inc, China
  • Yi Zhun Zhu
    Professor, Dean of Pharmacology, Fudan University, China
testimonials_03testimonials_06testimonials_01testimonials_04testimonials_05testimonials_02